Cromos Pharma Poland Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Secondary Activities: Pharmaceutical and Medicine Manufacturing | Merchant Wholesalers, Durable Goods | Pipeline Transportation | Warehousing and Storage | Architectural, Engineering, and Related Services | Administrative Management and General Management Consulting Services | Scientific Research and Development Services | Advertising, Public Relations, and Related Services | Marketing Research and Public Opinion Polling | All Other Professional, Scientific, and Technical Services

Full name: Cromos Pharma Poland Sp. z o.o.

Profile Updated: January 16, 2026

Cromos Pharma Poland Sp. z o.o. is based in Poland, with the head office in Warsaw. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was incorporated on September 20, 2022. Over the same period, its total assets grew by 485.91%.

Headquarters
Ul. Marszalkowska 58
Warsaw; Mazowieckie; Postal Code: 00-545

Contact Details: Purchase the Cromos Pharma Poland Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Cromos Pharma Poland Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Cromos Pharma Poland Sp. z o.o. report to view the information.

Incorporation Date:

September 20, 2022

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Cromos Pharma Poland Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Operating Profit

N/A

Net Profit/Loss for the Period

N/A

Total Assets

485.91%▲

Total Equity

223.25%▲

Return on Equity (ROE)

N/A

Quick Ratio

-31.48%▼

Cash Ratio

-31.75%▼

Similar companies